Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer

Name: Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer
License: Public Domain

Fujian Medical University Union Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

immunotherapy;envafolimab; esophageal cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 136339
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.